SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-197738
Filing Date
2023-07-28
Accepted
2023-07-28 16:27:32
Documents
20
Period of Report
2023-07-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d472066d8k.htm   iXBRL 8-K 35864
2 EX-5.1 d472066dex51.htm EX-5.1 9867
3 EX-10.1 d472066dex101.htm EX-10.1 197613
4 EX-10.2 d472066dex102.htm EX-10.2 77263
5 EX-10.3 d472066dex103.htm EX-10.3 33869
6 EX-10.4 d472066dex104.htm EX-10.4 6126
7 EX-99.1 d472066dex991.htm EX-99.1 7951
12 GRAPHIC g472066dsp5.jpg GRAPHIC 9419
  Complete submission text file 0001193125-23-197738.txt   646066

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA celu-20230727.xsd EX-101.SCH 4439
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20230727_def.xml EX-101.DEF 13852
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20230727_lab.xml EX-101.LAB 23317
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20230727_pre.xml EX-101.PRE 14820
14 EXTRACTED XBRL INSTANCE DOCUMENT d472066d8k_htm.xml XML 5864
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 231123474
SIC: 2834 Pharmaceutical Preparations